Results 71 to 80 of about 22,744 (213)

Concordance of Radiological, Laparoscopic and Laparotomic Scoring to Predict Complete Cytoreduction in Women with Advanced Ovarian Cancer [PDF]

, 2023
Mariano Catello Di Donna, Giuseppe Cucinella, Giulia Zaccaria, Giuseppe Lo Re, Agata Crapanzano, Sergio Salerno, Vincenzo Giallombardo, Giulio Sozzi, Anna Fagotti, Giovanni Scambia, Antonio Simone Laganà, Vito Chiàntera   +11 more
openalex   +1 more source

Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents

European Journal of Haematology, Volume 116, Issue 2, Page 160-168, February 2026.
ABSTRACT Acute myeloid leukemia (AML) in elderly patients presents a major therapeutic challenge, as many are deemed unfit for intensive chemotherapy due to age, comorbidities, or frailty. Venetoclax in combination with hypomethylating agents (HMA) has emerged as a standard‐of‐care for this population, yet outcomes remain heterogeneous and predictive ...
Ernesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, Andrea Corsonello, Santino Caserta, Caterina Labanca, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Nicola Amodio, Fortunato Morabito, Massimo Gentile   +11 more
wiley   +1 more source

Debulking Surgery, Survival Outcomes, and Rehabilitation in Advanced Ovarian Cancer: A Narrative Review [PDF]

Balneo and PRM Research Journal
Complete macroscopic cytoreduction is the most robust modifiable prognostic factor in advanced epithelial ovarian cancer. However, the relative value of primary debulking sur-gery (PDS) versus interval debulking surgery (IDS) after neoadjuvant ...
Alexandra Ligia Dinca, Valeriu Gabi Dinca, Cristina Daia, Cristian Daniel Marica, Raluca Elena Marica, Ioan Sorin Tudorache, Alina Mihaela Dobre, Mirela Coroescu, Luiza Maria Baean, Monica Octavia Muraru, Madalina Criveanu, Rodica Daniela Birla, Diana Mihaela Ciuc   +12 more
doaj   +1 more source

T‐Cell–Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions

European Journal of Haematology, Volume 116, Issue 2, Page 129-141, February 2026.
ABSTRACT Relapsed/refractory (R/R) mantle cell lymphoma (MCL) remains a therapeutic challenge, particularly in patients with high‐risk features or prior exposure to Bruton's tyrosine kinase inhibitors (BTKis). The advent of T‐cell–redirecting immunotherapies, including chimeric antigen receptor T‐cell (CAR‐T) therapy and bispecific antibodies (BsAbs ...
Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Safety and Efficacy of Pre-Cytoreduction Prior to Definitive Multi-Agent Chemotherapy in Aggressive Lymphoma

Pakistan Journal of Medicine and Dentistry
Background: Pre-cytoreduction refers to the administration of initial chemotherapy to reduce tumor burden prior to initiating definitive multi-agent chemotherapy.
Reena Kumari Sunil, Tariq Siddique, Sunil Kumar, Samina Shamim   +3 more
doaj   +1 more source

The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer

Journal of Ovarian Research, 2019
Background The aim of this study was to (1) evaluate the ability of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) parameters to predict suboptimal cytoreduction and (2) to create a risk model for predicting ...
Gun Oh. Chong, Shin Young Jeong, Yoon Hee Lee, Hyun Jung Lee, Sang-Woo Lee, Hyung Soo Han, Dae Gy Hong, Yoon Soon Lee   +7 more
doaj   +1 more source

Inguinal Lymph Node Metastasis of a Primary Serous Papillary Carcinoma of the Peritoneum One Year after CRS and HIPEC [PDF]

, 2018
Background: Primary peritoneal serous papillary carcinoma is a rare malignant epithelial tumor which was first described in 1959. Peritoneal serous papillary carcinoma arises from the peritoneal epithelium and originates from a single or multicentric ...
Brandl, Andreas, Feist, Mathilde, Katou, Shadi, Pratschke, Johann, Rau, Beate, Raue, Wieland   +5 more
core   +1 more source

Long‐term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinoma

BJUI Compass, Volume 7, Issue 1, January 2026.
Abstract Objectives To assess treatment outcomes and evaluate patient selection criteria for cytoreductive partial nephrectomy (CRPN) in a unique cohort of metastatic renal cell carcinoma (mRCC) patients. Methods A retrospective review of mRCC patients who underwent CRPN between 1995 and 2023 at a single institution was performed.
Andrea Lopez Sanmiguel, Yash S. Khandwala, Emily A. Vertosick, Daniel Barbakoff, Roya Ghavamian, Jonathan A. Coleman, Mark Dawidek, Andrew J. Vickers, A. Ari Hakimi, Paul Russo   +9 more
wiley   +1 more source

The robotic future of minimally invasive cytoreduction and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies [PDF]

, 2023
Joanna Ortega, Theofano Orfanelli, Edward A. Levine, Ioannis T. Konstantinidis   +3 more
openalex   +1 more source

Prognostic Factors and Nomogram‐Based Prediction Models for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis Undergoing Cytoreductive Surgery: A Retrospective Cohort Study

Cancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background Colorectal cancer (CRC) with synchronous peritoneal metastasis (SPM) presents poor prognosis and complex treatment challenges. This study aimed to identify independent prognostic factors and develop nomogram‐based prediction models for overall survival (OS) and progression‐free survival (PFS) in CRC patients with SPM (CRC‐SPM ...
Xiaoxu Ge, Guanli Yang, Huiming Wu, Lei Liu, Ming Zhou, Akao Zhu, Xiangxing Kong, Jingjing Wu, Yeting Hu, Kefeng Ding, Lifeng Sun, Jian Wang   +11 more
wiley   +1 more source